When Mn2+ is combined with PD-1 antibody, the tumor therapeutic effect of PD-1 antibody can be significantly enhanced in a variety of tumor models (139), and the synergistic effect of manganese and TGF-β/PD-L1 bispecific antibody YM101 can also show significant tumor inhibition (140). This evidence concerns the gene CD274 and neoplasm.